Cwm, LLC Igm Biosciences, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Cwm, LLC holds 17 shares of IGMS stock, worth $293. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 9 88.89%

Holding current value

$293

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$6.28 - $17.68 $50 - $141	8 Added 88.89%	17 $0
Q2 2024 Jul 09, 2024	BUY	$6.51 - $11.47 $52 - $91	8 Added 800.0%	9 $0
Q1 2024 Apr 05, 2024	BUY	$8.68 - $17.36 $8 - $17	1 New	1 $0

Others Institutions Holding IGMS

# of Institutions

Shares Held

21.4M

Call Options Held

39.5K

Put Options Held

16.5K

Baker Bros. Advisors LP New York, NY

4.09M
Shares

$70.6 Million
0.37% of portfolio
Price T Rowe Associates Inc Baltimore, MD

4.08M
Shares

$70.3 Million
0.0% of portfolio
Artal Group S.A. Luxembourg, N4

3.33M
Shares

$57.5 Million
1.45% of portfolio
Redmile Group, LLC San Francisco, CA

3.07M
Shares

$53 Million
1.38% of portfolio
Goldman Sachs Group Inc New York, NY

1.33M
Shares

$23 Million
0.0% of portfolio

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account